Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Braicu, Cornelia, Pileczki, Valentina, Pop, Laura, Petric, Roxana Cojocneanu, Chira, Sergiu, Pointiere, Eve, Achimas-Cadariu, Patriciu, Berindan-Neagoe, Ioana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4388814/
https://ncbi.nlm.nih.gov/pubmed/25849487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120936
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller